Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-1.30	64.86	65.72
Graham Fair Price	10.80	7.07	6.38
PEG	133.14	1.47	0.63
Price/Book	2.14	3.01	2.95
Price/Cash Flow	-14.65	49.19	57.64
Prices/Earnings	-13.40	29.32	33.86
Price/Sales	4.86	12.19	11.62
Price/FCF	-14.65	49.19	57.64
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-0.90	0.43	0.43
Operating Margin	10.99	0.15	0.14
ROA	19.19	0.01	0.01
ROE	0.02	0.03	17.95
ROIC	0.02	0.02	13.85
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.01	-0.01	-3.07
Dividends QOQ	< 0.005	< 0.005	-38.08
EBIT QOQ	0.25	0.10	-61.92
EPS QOQ	0.54	0.20	-62.86
FCF QOQ	407.50	0.21	-99.95
Revenue QOQ	0.08	-0.01	-85.76
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	122.95	111.98	-8.93
Days Sales Outstanding (DSO)	55.09	53.74	-2.44
Inventory Turnover	0.73	0.80	9.80
Debt/Capitalization	0.27	0.27	-0.02
Quick Ratio	1.51	1.79	18.36
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	9.12	9.30	2.02
Cash	0.59	1.00	69.01
Capex	-0.03	-0.03	18.18
Free Cash Flow	0.47	0.57	22.09
Revenue	2.31	2.30	-0.63
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	2.98	3.14	5.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.25	5.29	-15.40
Naive Interpretation	Member

06 - Financial Health · Bad

Rating